Steeneck; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Steeneck; Christoph.The latest application filed is for "aryl hydrocarbon receptor (ahr) modulator compounds".

Company Profile

9.28.38

Steeneck; Christoph - Heidelberg DE
Steeneck; Christoph - Dossenheim DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aryl hydrocarbon receptor (AhR) modulator compounds Grant 11,376,241 - Steeneck , et al. July 5, 2	2022-07-05
Aryl Hydrocarbon Receptor (ahr) Modulator Compounds App 20210260045 - STEENECK; Christoph ; et al.	2021-08-26
Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase Grant 11,078,168 - Steeneck , et al. August 3, 2	2021-08-03
Spirocyclic Compounds As Modulators Of Indoleamine 2,3-dioxygenase App 20210122757 - KINZEL; Olaf ; et al.	2021-04-29
Aryl hydrocarbon receptor (AHR) modulator compounds Grant 10,981,908 - Steeneck , et al. April 20, 2	2021-04-20
Oxalamides As Modulators Of Indoleamine 2,3-dioxygenase App 20200352931 - Steeneck; Christoph ; et al.	2020-11-12
Aryl Hydrocarbon Receptor (ahr) Modulator Compounds App 20200031805 - DEUSCHLE; Ulrich ; et al.	2020-01-30
Aryl Hydrocarbon Receptor (ahr) Modulator Compounds App 20190389857 - STEENECK; Christoph ; et al.	2019-12-26
FXR (NR1H4) binding and activity modulating compounds Grant 10,485,795 - Kinzel , et al. Nov	2019-11-26
Substituted N-hydroxyamidinoheterocycles As Modulators Of Indoleamine 2,3-dioxygenase App 20190292160 - Steeneck; Christoph ; et al.	2019-09-26
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[.gamma.] Grant 10,301,272 - Gege , et al.	2019-05-28
Novel FXR (NR1H4) binding and activity modulating compounds App 20190142814 - Kinzel; Olaf ; et al.	2019-05-16
FXR (NR1H4) binding and activity modulating compounds Grant 10,220,027 - Kinzel , et al.	2019-03-05
Trifluoromethyl alcohols as modulators of ROR.gamma.t Grant 10,150,762 - Goldberg , et al. Dec	2018-12-11
Thiazoles as modulators of ROR.gamma.t Grant 10,080,744 - Goldberg , et al. September 25, 2	2018-09-25
Novel FXR (NR1H4) binding and activity modulating compounds App 20180200243 - Kinzel; Olaf ; et al.	2018-07-19
THIAZOLES AS MODULATORS OF RORyt App 20180064690 - Goldberg; Steven ; et al.	2018-03-08
Thiazoles as modulators of ROR.gamma.t Grant 9,861,618 - Goldberg , et al. January 9, 2	2018-01-09
Trifluoromethyl alcohols as modulators of ROR.gamma.t Grant 9,850,236 - Goldberg , et al. December 26, 2	2017-12-26
Amide substituted thiazoles as modulators of RORyt Grant 9,845,319 - Goldberg , et al. December 19, 2	2017-12-19
FXR (NR1H4) binding and activity modulating compounds Grant 9,820,979 - Kinzel , et al. November 21, 2	2017-11-21
TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF RORyt App 20170327492 - Goldberg; Steven ; et al.	2017-11-16
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR.gamma., NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases Grant 9,815,851 - Steeneck , et al. November 14, 2	2017-11-14
Novel Fxr (nr1h4) Binding And Activity Modulating Compounds App 20170143684 - Kinzel; Olaf ; et al.	2017-05-25
FXR (NR1H4) binding and activity modulating compounds Grant 9,539,244 - Kinzel , et al. January 10, 2	2017-01-10
Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor ROR.gamma. Grant 9,458,104 - Gege , et al. October 4, 2	2016-10-04
AMIDE SUBSTITUTED THIAZOLES AS MODULATORS OF RORyt App 20160122335 - Goldberg; Steven ; et al.	2016-05-05
TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF RORyt App 20160122336 - Goldberg; Steven ; et al.	2016-05-05
THIAZOLES AS MODULATORS OF RORyt App 20160120850 - Goldberg; Steven ; et al.	2016-05-05
Carboxamide Or Sulfonamide Substituted Nitrogen-containing 5-membered Heterocycles As Modulators For The Orphan Nuclear Receptor Ror Gamma App 20150344423 - GEGE; Christian ; et al.	2015-12-03
Novel Fxr (nr1h4) Binding And Activity Modulating Compounds App 20150342930 - Kinzel; Olaf ; et al.	2015-12-03
FXR (NR1H4) binding and activity modulating compounds Grant 9,139,539 - Kinzel , et al. September 22, 2	2015-09-22
Carboxamide Or Sulfonamide Substituted Thiazoles And Related Derivatives As Modulators For The Orphan Nuclear Receptor Ror[gamma] App 20150175562 - Gege; Christian ; et al.	2015-06-25
FXR (NR1H4) binding and activity modulating compounds Grant 8,952,042 - Kremoser , et al. February 10, 2	2015-02-10
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-.gamma. (ROR-.gamma., NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases Grant 8,946,446 - Steeneck , et al. February 3, 2	2015-02-03
Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR.gamma., NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease Grant 8,940,722 - Kinzel , et al. January 27, 2	2015-01-27
PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES App 20140349987 - Steeneck; Christoph ; et al.	2014-11-27
Heterobicyclic metalloprotease inhibitors Grant 8,835,441 - Steeneck , et al. September 16, 2	2014-09-16
Novel Fxr (nr1h4) Binding And Activity Modulating Compounds App 20140221659 - Kinzel; Olaf ; et al.	2014-08-07
Pyrrolo Sulfonamide Compounds For Modulation Of Orphan Nuclear Receptor Rar-related Orphan Receptor-gamma (ror-gamma, Nr1f3) Activity And For The Treatment Of Chronic Inflammatory And Autoimmune Diseases App 20140142082 - Steeneck; Christoph ; et al.	2014-05-22
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease App 20130053380 - Kinzel; Olaf ; et al.	2013-02-28
Novel Fxr (nr1h4) Binding And Activity Modulating Compounds App 20120232116 - Kremoser; Claus ; et al.	2012-09-13
Heterobicyclic Metalloprotease Inhibitors App 20120015920 - Steeneck; Christoph ; et al.	2012-01-19
Dipeptidyl peptidase-IV inhibitors Grant 8,076,330 - Kroth , et al. December 13, 2	2011-12-13
Dipeptidyl Peptidase-IV Inhibitors App 20110112051 - KROTH; Heiko ; et al.	2011-05-12
Heterobicyclic metalloprotease inhibitors Grant 7,795,245 - Steeneck , et al. September 14, 2	2010-09-14
Heterobicyclic metalloprotease inhibitors Grant 7,713,966 - Gege , et al. May 11, 2	2010-05-11
Dipeptidyl Peptidase-iv Inhibitors App 20100009961 - Kroth; Heiko ; et al.	2010-01-14
Heterobicyclic Metalloprotease Inhibitors App 20090312312 - STEENECK; Christoph ; et al.	2009-12-17
Heterobicyclic metalloprotease inhibitors App 20090137547 - Steeneck; Christoph ; et al.	2009-05-28
Heterobicyclic metalloprotease inhibitors App 20080261968 - Gege; Christian ; et al.	2008-10-23
Heterobicyclic metalloprotease inhibitors App 20080176870 - Nolte; Bert ; et al.	2008-07-24
Heterobicyclic metalloprotease inhibitors App 20080161300 - Steeneck; Christoph ; et al.	2008-07-03
Metalloprotease inhibitors App 20080021024 - Sucholeiki; Irving ; et al.	2008-01-24
Substituted bis-amide metalloprotease inhibitors App 20070155739 - Sucholeiki; Irving ; et al.	2007-07-05
Heterobicyclic metalloprotease inhibitors App 20070155738 - Steeneck; Christoph ; et al.	2007-07-05
Heterobicyclic metalloprotease inhibitors App 20060293345 - Steeneck; Christoph ; et al.	2006-12-28
Multicyclic bis-amide MMP inhibitors App 20060173183 - Powers; Timothy ; et al.	2006-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.